14M163: Abstracts: Antiphospholipid Syndrome (2268–2271)

Abstract Moderator(s)

• RR

  Robert Roubey, MD

  University of North Carolina
  Chapel Hill, NC, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Maria Laura Bertolaccini, PhD

  King's College London
  London, United Kingdom

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 5:00 PM – 5:10 PM Eastern Time

  Recurrent Thrombosis Risk in Non-anticoagulated Antiphospholipid Syndrome Patients: A Prospective Case-Control Study from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  

  Presenting Author: Cecile Yelnik, PhD – lille university
• 5:10 PM – 5:15 PM Eastern Time

  Q&A
  
• 5:15 PM – 5:20 PM Eastern Time

  Anti-NET Antibodies in Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  

  Presenting Author: Yu (Ray) Zuo, MD, MS – University of Michigan
• 5:20 PM – 5:30 PM Eastern Time

  Q&A
  
• 5:30 PM – 5:40 PM Eastern Time

  Evidence for Mitochondrial Dysfunction in Blood-derived Endothelial Colony Forming Cells Isolated from Patients with Antiphospholipid Syndrome
  

  Presenting Author: Charis Pericleous, PhD – Imperial College London
• 5:40 PM – 5:45 PM Eastern Time

  Q&A
  
• 5:45 PM – 5:55 PM Eastern Time

  Circulating Calprotectin: A Potential New Biomarker for “Non-Criteria" Clinical Manifestations of Antiphospholipid Syndrome
  

  Presenting Author: Claire Hoy, BS – University of Michigan
• 5:55 PM – 6:00 PM Eastern Time

  Q&A